Developing regions vs Malta: Proportion of the target population who received the final dose
Developing regions
26.0%
in 2024
Malta
80.0%
in 2024
Developing regions rank
24th
Malta rank
23rd
Proportion of the target population who received the final dose over time
- Developing regions
- Malta
How they compare
Malta currently reports 80.0% against 26.0% in Developing regions, a difference of 54.0%.
That makes Malta's figure about 3.1 times Developing regions's.
Across all 12 years both countries report, Malta has been ahead every year.
Developing regions ranks 24th and Malta ranks 23rd of 34 groups.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developing regions | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7.1% | 81.4% | 74.3% | Malta |
| 2020s | 14.0% | 82.8% | 68.8% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Developing regions or Malta?
- Malta, at 80.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Developing regions and Malta?
- 54.0%, with Malta ahead.
- How many years of comparable data are there for Developing regions and Malta?
- 12 years are reported by both, from 2013 to 2024.
- How do Developing regions and Malta rank globally for proportion of the target population who received the final dose of?
- Developing regions ranks 24th and Malta ranks 23rd of 34 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.